-
-
Chelation therapy for cardiovascular disease; statins and kidney injuries; chlorthalidone for hypertension; and FDA actions.
-
Aspirin use and AMD risk; using NSAIDs and antihypertensive agents; and FDA actions.
-
-
Disproportionately longer time was allocated to ICU patients discussed early in attending physician handoff sessions, regardless of complexity or severity of illness.
-
Aspirin therapy, as compared with placebo, significantly reduced the rate of major vascular events with improved net clinical benefit and also reduced the rate of recurrent venous thromboembolism.
-
Atrial fibrillation (AF) and stroke are common in patients with chronic kidney disease (CKD), but many such patients are not anticoagulated for fear of bleeding complications.
-
A surgeon reported having suffered a sharps injury while performing an orthopedic procedure.
-
-
A total of 27,276 U.S. physicians received an invitation to participate in a prospective study using the validated Maslach Burnout Inventory.
